ANXA1 and colitis: While the findings here described utilizing a murine model of experimental colitis so far evidence there is a connection between pioglitazone actions and AnxA1, assessment of AnxA1 as a marker of disease progression under pioglitazone treatment should still be considered in a preliminary manner and approached with due reservations in further studies involving humans.